BLOOD-PRESSURE BEHAVIOR IN PATIENTS ON CHRONIC-HEMODIALYSIS (CH) TREATED WITH SUBCUTANEOUS AND ENDOVENOUS (EV) ERYTHROPOIETIN (EPO)

被引：0
作者：
AMAYA, L [1 ]
BONELLI, CA [1 ]
PEREZ, N [1 ]
CHAMORRO, A [1 ]
OLMOS, Z [1 ]
BRUSCO, P [1 ]
VELAZQUEZ, J [1 ]
GUITIAN, N [1 ]
CASTRO, I [1 ]
机构：
[1] CENT MIL HOSP, BUENOS AIRES, ARGENTINA
来源：
KIDNEY INTERNATIONAL | 1993年 / 44卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1413 / 1413
页数：1
相关论文
共 50 条
[21]   EFFECTS OF EXERCISE TRAINING AND RECOMBINANT-HUMAN-ERYTHROPOIETIN (EPO) IN PATIENTS RECEIVING CHRONIC-HEMODIALYSIS [J].
SAM, MV ;
SWANEPOEL, C ;
NOAKES, TD .
KIDNEY INTERNATIONAL, 1993, 43 (05) :1182-1182
[22]   A MARKOV COST-UTILITY MODEL ON THE PROVISION OF ERYTHROPOIETIN (EPO) FOR CHRONIC-HEMODIALYSIS (HD) PATIENTS [J].
MANALICH, J ;
GOEL, V ;
CHURCHILL, DN .
MEDICAL DECISION MAKING, 1991, 11 (04) :323-323
[23]   BLOOD-PRESSURE BEHAVIOR IN HEMODIALYSIS-PATIENTS TREATED FOR 10 YEARS [J].
ESPOSTI, ED ;
BOERO, R ;
CHIARINI, C ;
NEGRONI, D ;
QUARELLO, F ;
SANTORO, A ;
STURANI, A ;
ZUCCALA, A ;
PICCOLI, G ;
ZUCCHELLI, P .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1983, 6 (03) :121-126
[24]   MULTIPLE AMBULATORY BLOOD-PRESSURE (ABP) MEASUREMENTS AT THE SAME HEMATOCRIT (HCT) ON AND OFF ERYTHROPOIETIN (EPO) IN PATIENTS ON HEMODIALYSIS [J].
TOBE, SW ;
SAIPHOO, C ;
MANUEL, MA ;
PERKINS, N ;
BJARNASON, GA .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03) :569-569
[25]   PLASMA ENDOTHELIN LEVELS AND BLOOD-PRESSURE IN HEMODIALYSIS AND IN CAPD PATIENTS - EFFECT OF SUBCUTANEOUS ERYTHROPOIETIN REPLACEMENT THERAPY [J].
LEBEL, M ;
GROSE, JH ;
KINGMA, I ;
LANGLOIS, S .
CLINICAL AND EXPERIMENTAL HYPERTENSION, 1994, 16 (05) :565-575
[26]   24-HOUR BLOOD-PRESSURE AND HEART-RATE PATTERNS IN CHRONIC-HEMODIALYSIS PATIENTS [J].
VANDEBORNE, P ;
TIELEMANS, C ;
COLLART, F ;
VANHERWEGHEM, JL ;
DEGAUTE, JP .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 22 (03) :419-425
[27]   EFFECTS OF PRAZOSIN AND PROPRANOLOL ON BLOOD-PRESSURE AND PLASMA-LIPIDS IN PATIENTS UNDERGOING CHRONIC-HEMODIALYSIS [J].
MELTZER, VN ;
GOLDBERG, AP ;
TINDIRA, CA ;
NAUMOVICH, AD ;
HARTER, HR .
AMERICAN JOURNAL OF CARDIOLOGY, 1984, 53 (03) :A40-A45
[28]   PLASMA ANP LEVELS, BODY-FLUID STATUS AND BLOOD-PRESSURE IN CHRONIC-HEMODIALYSIS PATIENTS [J].
KUMAGAI, H ;
HIRAKATA, H ;
PAGANINI, EP ;
MAGNUSSON, MO ;
NAKAMOTO, S ;
BRAVO, EL ;
FOUADTARAZI, FM .
CLINICAL RESEARCH, 1989, 37 (04) :A904-A904
[29]   GENETIC PREDISPOSITION TO HYPERTENSION FACILITATES BLOOD-PRESSURE ELEVATION IN HEMODIALYSIS-PATIENTS TREATED WITH ERYTHROPOIETIN [J].
ISHIMITSU, T ;
TSUKADA, H ;
OGAWA, Y ;
NUMABE, A ;
YAGI, S .
AMERICAN JOURNAL OF MEDICINE, 1993, 94 (04) :401-406
[30]   THE CLINICAL EFFECTS AND SIDE-EFFECTS OF RECOMBINANT HUMAN ERYTHROPOIETIN (EPO) IN ANEMIC PATIENTS ON CHRONIC-HEMODIALYSIS [J].
不详 .
KIDNEY INTERNATIONAL, 1990, 37 (01) :278-278
12345